Novozymes Debt to Equity Ratio 2011-2023 | NVZMY

Current and historical debt to equity ratio values for Novozymes (NVZMY) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Novozymes debt/equity for the three months ending December 31, 2023 was 0.30.
Novozymes Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2023-12-31 $2.04B $2.08B 0.98
2023-09-30 $1.99B $2.17B 0.92
2023-06-30 $2.11B $2.02B 1.05
2023-03-31 $2.16B $1.92B 1.13
2022-12-31 $1.95B $2.02B 0.97
2022-09-30 $1.89B $1.90B 0.99
2022-06-30 $2.00B $1.79B 1.12
2022-03-31 $2.05B $1.76B 1.16
2021-12-31 $2.00B $1.94B 1.03
2021-09-30 $1.63B $1.84B 0.89
2021-06-30 $1.74B $1.77B 0.98
2021-03-31 $1.77B $1.75B 1.01
2020-12-31 $1.42B $1.72B 0.82
2020-09-30 $1.46B $1.70B 0.86
2020-06-30 $1.46B $1.60B 0.92
2020-03-31 $1.43B $1.59B 0.90
2019-12-31 $1.34B $1.72B 0.78
2019-09-30 $1.33B $1.67B 0.80
2019-06-30 $1.36B $1.66B 0.82
2019-03-31 $1.44B $1.66B 0.87
2018-12-31 $1.31B $1.81B 0.72
2018-09-30 $1.25B $1.71B 0.73
2018-06-30 $1.30B $1.72B 0.76
2018-03-31 $1.37B $1.69B 0.81
2017-12-31 $1.08B $1.71B 0.63
2017-09-30 $1.16B $1.70B 0.68
2017-06-30 $1.09B $1.58B 0.69
2017-03-31 $1.13B $1.57B 0.72
2016-12-31 $1.03B $1.75B 0.59
2016-09-30 $1.03B $1.65B 0.62
2016-06-30 $1.03B $1.67B 0.62
2016-03-31 $1.02B $1.57B 0.65
2015-12-31 $0.92B $1.73B 0.54
2015-09-30 $1.02B $1.66B 0.61
2015-06-30 $1.06B $1.66B 0.64
2015-03-31 $1.09B $1.71B 0.64
2014-12-31 $1.27B $2.01B 0.63
2014-09-30 $1.39B $1.97B 0.70
2014-06-30 $1.36B $1.99B 0.68
2014-03-31 $1.29B $1.96B 0.66
2013-12-31 $0.95B $1.94B 0.49
2013-09-30 $0.95B $1.88B 0.50
2013-06-30 $1.06B $1.76B 0.60
2013-03-31 $1.15B $1.71B 0.68
2012-12-31 $0.96B $1.65B 0.58
2012-09-30 $0.90B $1.55B 0.58
2012-06-30 $0.92B $1.53B 0.60
2012-03-31 $0.89B $1.52B 0.59
2011-12-31 $0.94B $1.65B 0.57
2011-09-30 $1.00B $1.59B 0.63
2011-06-30 $0.98B $1.57B 0.62
2011-03-31 $0.98B $1.42B 0.69
2010-12-31 $0.85B $1.39B 0.61
Sector Industry Market Cap Revenue
Basic Materials Chemicals - Specialty $25.583B $2.598B
Novozymes A/S is primarily engaged in the development, production, and distribution of enzymes. Its business consists of two segments, enzyme business and bio business. The Company's enzyme business segment offers detergent enzymes that are used in laundry and dishwashing, technical enzymes used in the transformation of starch into different kinds of sugars and have application in leather, textile, and forest product industries, food enzymes used in production of bread, wine, juice, beer, noodles, alcohol, and pasta and feed enzymes used in animal feed. Its bio business segment offers microorganisms that are used in industrial and municipal wastewater treatment, as well as in the cleaning of surfaces such as carpet, concrete, drain lines, and septic tanks in industrial and household applications. It also has application in the Biopharmaceutical ingredients used in pharmaceutical industry. Novozymes A/S is headquartered in Bagsvaerd, Denmark.
Stock Name Country Market Cap PE Ratio
Linde (LIN) United Kingdom $215.462B 31.49
Ecolab (ECL) United States $63.384B 42.55
Givaudan SA (GVDNY) Switzerland $39.446B 0.00
PPG Industries (PPG) United States $31.640B 17.53
Celanese (CE) United States $16.994B 17.49
Croda (COIHY) United Kingdom $8.186B 0.00
Axalta Coating Systems (AXTA) United States $6.992B 20.10
Element Solutions (ESI) United States $5.957B 19.08
NewMarket (NEU) United States $5.684B 14.66
Valvoline (VVV) United States $5.413B 31.16
Orbia Advance, S.A.B De C.V (MXCHY) Mexico $4.851B 0.00
Balchem (BCPC) United States $4.772B 44.15
Ashland (ASH) United States $4.771B 27.05
Nissan Chemical (NNCHY) Japan $4.769B 19.20
Arcadium Lithium (ALTM) United States $4.416B 2.17
H B Fuller (FUL) United States $4.137B 19.08
CSW Industrials (CSWI) United States $3.666B 35.18
Quaker Houghton (KWR) United States $3.486B 25.33
Sensient Technologies (SXT) United States $2.893B 23.81
Minerals Technologies (MTX) United States $2.299B 13.64
Ingevity (NGVT) United States $1.642B 11.55
Hawkins (HWKN) United States $1.617B 22.19
DAQO New Energy (DQ) China $1.533B 4.31
Green Plains (GPRE) United States $1.418B 0.00
Orion S.A (OEC) United States $1.408B 12.60
Perimeter Solutions, SA (PRM) Luxembourg $1.140B 60.42
ELEMENTIS (ELMTY) United Kingdom $1.114B 0.00
Mativ Holdings (MATV) United States $0.946B 14.52
Huabao Holdings (HUIHY) Hong Kong, SAR China $0.943B 0.00
Westlake Chemical Partners LP (WLKP) United States $0.774B 14.27
AdvanSix (ASIX) United States $0.733B 14.92
NL Industries (NL) United States $0.387B 0.00
Westaim (WEDXF) Canada $0.339B 2.02
American Vanguard (AVD) United States $0.337B 43.30
5E Advanced Materials (FEAM) United States $0.054B 0.00